Corrigendum to “D-saccharic acid 1,4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-κB and PKC signaling” [Toxicology and Applied Pharmacology, 267 (2013) 16–29, (S0041008X12005327), (10.1016/j.taap.2012.12.005)];D-Saccharic acid 1,4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-κB and PKC signaling

Toxicology and Applied Pharmacology

Volumn 267, Issue 1, 2013, Pages 16-29

  Bhattacharya, Semantee ^a   Manna, Prasenjit ^b   Gachhui, Ratan ^a   Sil, Parames C ^b  

^a JADAVPUR UNIVERSITY   (India)

^b BOSE INSTITUTE   (India)

Author keywords

Aldose reductase; Antioxidant; D Saccharic acid 1,4 lactone; Diabetic renal injury; NF B and inflammation; PKC

Indexed keywords

ALDEHYDE REDUCTASE; COLLAGEN; CREATININE; CYTOKINE; FIBRONECTIN; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; REACTIVE OXYGEN METABOLITE; SACCHAROLACTONE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARBONYLATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; KIDNEY DYSFUNCTION; KIDNEY INJURY; LIPID PEROXIDATION; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SIGNAL TRANSDUCTION; UREA NITROGEN BLOOD LEVEL;

RATTUS;

EID: 84872026139     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2024.116828     Document Type: Erratum

References (54)

1. Ahmad F.K., Zhiheng H., King G.L. Molecular targets of diabetic cardiovascular complications. Curr. Drug Targets 2005, 6:487-494.
2. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 1994, 12:141-179.
3. Baldwin A.S. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
4. Baynes J.W. Role of oxidative stress in development of complication of diabetes. Diabetes 1991, 40:405-412.
5. Bhattacharya S., Chatterjee S., Manna P., Das J., Ghosh J., Gachhui R., Sil P.C. Prophylactic role of d-saccharic acid-1,4-lactone in tertiary butyl hydroperoxide induced cytotoxicity and cell death of murine hepatocytes via mitochondria dependent pathways. J. Biochem. Mol. Toxicol. 2011, 25:341-354.
6. Bhattacharya S., Manna P., Gachhui R., Sil P.C. d-Saccharic acid-1,4-lactone ameliorates alloxan-induced diabetes mellitus and oxidative stress in rats through inhibiting pancreatic β-cells from apoptosis via mitochondrial dependent pathway. Toxicol. Appl. Pharmacol. 2011, 257:272-283.
7. Bloch-Damti A., Bashan N. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid. Redox Signal. 2005, 7:1553-1567.
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
9. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
10. Das J., Sil P.C. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. Amino Acids. 2012, 10.1007/s00726-012-1225-y.
11. Drel V.R., Xu W., Zhang J., Pavlov I.A., Shevalye H., Slusher B., Obrosova I.G. Poly(adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy. Endocrinology 2009, 150:5273-5283.
12. Elmarakby A.A., Sullivan J.C. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc. Ther. 2012, 30:49-59.
13. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990, 186:407-421.
14. Forbes J.M., Coughlan M.T., Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008, 57:1446-1454.
15. Hanausek M., Walasze Z., Slaga T.J. Detoxifying cancer causing agents to prevent cancer. Integr. Cancer Ther. 2003, 2:139-144.
16. Hashemi M., Dostar Y., Rohani S.R., AziziSaraji A.R., Bayat M. Influence of aloxanes on the apoptosis of pancreas B-cells of rat. World J. Med. Sci. 2009, 4:70-73.
17. Hissin P.J., Hilf R.A. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74:214-226.
18. Hodgkinson A.D., Sondergaard K.L., Yang B., Cross D.F., Millward B.A., Demaine A.G. Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy. Kidney Int. 2001, 60:211-218.
19. Horton D., Walaszek Z. Conformations of the d-glucarolactones and d-glucaric acid in solution. Carbohydr. Res. 1982, 105:95-109.
20. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., Aoki T., Etoh T., Hashimoto T., Naruse M., Sano H., Utsumi H., Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD (P) H oxidase in cultured vascular cells. Diabetes 2000, 49:1939-1945.
21. Iwamoto M., Mizuiri S., Arita M., Hemmi H. Nuclear factor-κB activation in diabetic rat kidney: evidence for involvement of P-selectin in diabetic nephropathy. Tohoku J. Exp. Med. 2005, 206:163-171.
22. Jain S.K. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J. Biol. Chem. 1989, 264:21340-21345.
23. Jang S.M., Kim M.J., Cho M.S., Kwon E.Y., Lee M.K. Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice. Metab. Clin. Exp. 2010, 59:512-519.
24. Kang E.S., Lee G.T., Kim B.S., Kim C.H., Seo G.H., Han S.J., Hur K.Y., Ahn C.W., Ha H., Jung M., Ahn Y.S., Cha B.S., Lee H.C. Litospermic acid B ameliorates the development of diabetic nephropathy in OLETF rats. Eur. J. Pharmacol. 2008, 579:418-425.
25. Kanwar Y.S., Wada J., Sun L., Xie P., Wallner E.I., Chen S., Chugh S., Danesh F.R. Diabetic nephropathy: mechanisms of renal disease progression. Exp. Biol. Med. 2008, 233:4-11.
26. Kayal R., Cakatay U., Telci A., Akcay T., Sivas A., Altug T. Decrease in mitochondrial oxidative protein damage parameters in the streptozotocin-diabetic rat. Diabetes Metab. Res. Rev. 2004, 20:315-321.
27. Kim J.S., Ju J.B., Choi C.W., Kim S.C. Hypoglycemic and antihyperlipidemic effect of four Korean medicinal plants in alloxan induced diabetic rats. Am. J. Biochem. Biotechnol. 2008, 2:154-160.
28. Kroemer G., Zamzanmi N., Susin S.A. Mitochondrial control of apoptosis. Immunol. Today 1997, 18:44-51.
29. Kumar P., Kale R.K., Baquer N.Z. Antihyperglycemic and protective effects of Trigonella foenum graecum seed powder on biochemical alterations in alloxan diabetic rats. Eur. Rev. Med. Pharmacol. Sci. 2012, 16:18-27.
30. Makino H., Miyamoto Y., Sawai K., Mori K., Mukoyama M., Nakao K., Yoshimasa Y., Suga S. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 2006, 55:2747-2756.
31. Manna P., Sinha M., Sil P.C. Prophylactic role of arjunolic acid in response to streptozotocin mediated diabetic renal injury: activation of polyol pathway and oxidative stress responsive signaling cascades. Chem. Biol. Interact. 2009, 181:297-308.
32. Meier M., Menne J., Park J.K., Haller H. Nailing down PKC isoform specificity in diabetic nephropathy - two's company, three's a crowd. Nephrol. Dial. Transplant. 2007, 22:2421-2425.
33. Navarro J.F., Mora C. Role of inflammation in diabetic complications. Nephrol. Dial. Transplant. 2005, 20:2601-2604.
34. Navarro-Gonzalez J.F., Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J. Am. Soc. Nephrol. 2008, 19:433-442.
35. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
36. Oberley L.W. Free radicals and diabetes. J. Biol. Chem. 1988, 5:113-124.
37. Olas B., Saluk-Juszcak J., Nowak P., Glowacki R., Bald E., Wachowicz B. Protective effects of d-glucaro 1,4-lactone against oxidative/nitrative modifications of plasma proteins. Nutrition 2007, 23:164-171.
38. Onozato M.L., Tojo A., Goto A., Fujita T., Wilcox C. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int. 2002, 61:186-194.
39. Rains J.L., Jain S.K. Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med. 2011, 50:567-575.
40. Ramana K.V., Friedrich B., Tammali R., West M.B., Bhatnagar A., Srivastava S.K. Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Diabetes 2006, 54:818-829.
41. Rashid K., Bhattacharya S., Sil P.C. Protective role of d-saccharic acid-1,4-lactone in alloxan induced oxidative stress in the spleen tissue of diabetic rats is mediated by suppressing mitochondria dependent apoptotic pathway. Free Radic. Res. 2012, 46:240-252.
42. Saluk-Juszcak J., Olas B., Nowak P., Staron A., Wachowicz B. Protective effects of d-glucaro 1,4-lactone against oxidative modifications in blood platelets. Nutr. Metab. Cardiovasc. 2008, 18:422-428.
43. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991, 10:2247-2258.
44. Shena F., Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J. Am. Nephrol. 2005, 16(Suppl. 1):s30-s33.
45. Sinha M., Manna P., Sil P.C. Taurine, a conditionally essential amino acid, ameliorates arsenic-induced cytotoxicity in murine hepatocytes. Toxicol. In Vitro 2007, 21:1419-1425.
46. Sotoa C., Péreza J., Garcíaa V., Uríab E., Vadilloc M., Rayac L. Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus. Phytomedicine 2010, 17:1090-1094.
47. Uchida K., Stadtman E.R. Covalent attachment of 4-hydroxynonenal to glyceraldehydes-3-phosphate dehydrogenase. J. Biol. Chem. 1993, 268:6388-6393.
48. Vasavada N., Agarwal R. Role of oxidative stress in diabetic nephropathy. Adv. Chronic Kidney Dis. 2005, 12:146-154.
49. Verma L., Singour P.K., Chaurasiya P.K., Rajak H., Pawar R.S., Patil U.K. Effect of ethanolic extract of Cassia occidentalis Linn. for the management of alloxan-induced diabetic rats. Pharmacogn. Res. 2010, 2:132-137.
50. Walaszek Z., Szemraj J., Hanausek M., Adams A.K., Sherman U. d-Glucaric acid content of various fruits and vegetables and cholesterol-lowering effects of dietary d-glucarate in the rat. Nutr. Res. 1996, 16:673-681.
51. Wei-hua L., Zi-qing H., Hong N., Fu-tian T., He-qing H., Xue-juan L., Yan-hui D., Shao-rui C., Fen-fen G., Wen-ge H., Feng-ying C., Pei-qing L. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin. Med. J. 2008, 121:706-712.
52. Woessner J.F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 1961, 93:440-447.
53. Wolff S.P., Dean R.T. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem. J. 1987, 245:243-250.
54. Zamzami N., Kroemer G. Methods to measure membrane potential and permeability transition in the mitochondria during apoptosis. Methods Mol. Biol. 2004, 282:103-115.